Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
S
S

Stryker

Balita

Reuters - 2 linggo ang nakaraan

Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing

BRIEF-Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing Sept 4 (Reuters) - Stryker Corp SYK.N : STRYKER FILES FOR OFFERING OF € DENOMINATED NOTES, SIZE NOT DISCLOSED - FILING Source text for Eikon: [ID:n0001193125-24-212577] Further company coverage: SYK.N
S
Reuters - 4 linggo ang nakaraan

U.S. STOCKS NetEase, Wolfspeed, B. Riley

BUZZ-U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
N
S
U
U
U
E
S
A
Reuters - 4 linggo ang nakaraan

U.S. STOCKS Evogene, Stryker, Opera

BUZZ-U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
B
I
N
U
U
U
E
S
A
Reuters - 4 linggo ang nakaraan

Stryker rises on deal to acquire Vertos Medical

BUZZ-Stryker rises on deal to acquire Vertos Medical ** Shares of medical device maker Stryker SYK.N rise 1.1% to $348.86 ** Co says it would acquire privately held Vertos Medical to expand its minimally invasive pain management portfolio ** Deal gives SYK access to Vertos' minimally invasive treatment for chronic lower back pain caused by lumbar s
S
Reuters - 4 linggo ang nakaraan

Stryker to acquire Vertos Medical

BRIEF-Stryker to acquire Vertos Medical Aug 22 (Reuters) - Stryker Corp SYK.N : STRYKER ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE VERTOS MEDICAL, INC., EXPANDING INTERVENTIONAL PAIN MANAGEMENT SOLUTIONS STRYKER: CO & VERTOS MEDICAL WILL CONTINUE TO OPERATE AS SEPARATE ENTITIES & PROCEED WITH BUSINESS AS USUAL UNTIL DEAL CLOSES Source text for Eikon
S
Reuters - 1 buwan ang nakaraan

Russian commander says Ukraine's forces pushing along the border front

UPDATE 1-Russian commander says Ukraine's forces pushing along the border front Russia evacuates district in Kursk Russian commander: one village taken back from Ukraine Ukrainian forces are pushing along the Kursk front Ukraine says its advance is 'going well' Intense fighting on other parts of front Russia shows U.S.-made Stryker being destroyed in Russia Adds Russia pushing out Ukrainian forces from one village, description of battle from Russian commander in paragraphs 1, 4-11, official visi
S
Reuters - 1 buwan ang nakaraan

Zimmer Biomet beats profit estimates on strong demand for medical devices

Zimmer Biomet beats profit estimates on strong demand for medical devices Aug 7 (Reuters) - Zimmer Biomet Holdings ZBH.N beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for its devices used in joint reconstruction procedures. Medical device makers have boosted investor expectations in the recent quarters as more people, especially older Americans, opt for non-urgent surgeries such as hip and knee replacements.
S
Z
Reuters - 1 buwan ang nakaraan

Baxter raises full-year profit forecast on robust demand for medical devices

Baxter raises full-year profit forecast on robust demand for medical devices Aug 6 (Reuters) - Baxter International BAX.N on Tuesday raised its annual profit expectations and beat Wall Street estimates for second-quarter profit on strong sales of its medical devices, driven by robust demand for medical care among patients. Shares of the company rose 3% to $35.69 in premarket trading.
S
Reuters - 2 buwan ang nakaraan

Teleflex raises 2024 profit forecast on medical device demand

Teleflex raises 2024 profit forecast on medical device demand Aug 1 (Reuters) - Surgical equipment maker Teleflex TFX.N raised its annual profit forecast on Thursday, banking on resilient demand for certain surgical procedures at hospitals to drive sales for its medical devices. The company also said its board authorized a share repurchase program for up to $500 million of common stock.
S
T
Reuters - 2 buwan ang nakaraan

Stryker beats Q2 profit estimates on robust demand for medical devices, implants

Stryker beats Q2 profit estimates on robust demand for medical devices, implants July 30 (Reuters) - Stryker Corp SYK.N posted an upbeat second-quarter profit on Tuesday, as demand for its medical and surgical devices rose, driven by growth in non-urgent surgeries. On an adjusted basis, the company reported a profit of $2.81 per share for the quarter ended June 30, slightly above analysts' estimates of $2.79 per share.
S
Reuters - 2 buwan ang nakaraan

Stryker Q2 Adjusted EPS USD 2.81 Vs. IBES Estimate USD 2.79

BRIEF-Stryker Q2 Adjusted EPS USD 2.81 Vs. IBES Estimate USD 2.79 Jul 30 (Reuters) - Stryker Q2 adjusted EBIT margin 24.6%. Q2 EPS USD 2.14 Q2 revenue USD 5,400 million vs. IBES estimate USD 5,406 million Q2 adjusted net income USD 1,085 million vs. IBES estimate USD 1,072 million Q2 adjusted gross margin 64.2% Q2 net income USD 825 million outlook
S
Reuters - 2 buwan ang nakaraan

Microsoft and job openings to hit pre-Fed vigil

MORNING BID AMERICAS-Microsoft and job openings to hit pre-Fed vigil A look at the day ahead in U.S. and global markets from Mike Dolan To the extent that worries about pricey tech stocks and rising AI capex spending were partly behind last week's market shakeout, Microsoft's quarterly update should prove a key moment later on Tuesday, just as the Federal Reserve's latest policy meeting gets under way.
A
A
E
G
I
M
M
N
P
S
U
A
G
J
U
U
U
F
E
E
S
A
H
L
Reuters - 2 buwan ang nakaraan

Stryker Corp <SYK.N> expected to post earnings of $2.79 a share - Earnings Preview

Stryker Corp expected to post earnings of $2.79 a share - Earnings Preview Stryker Corp SYK.N , SYK is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2024 The Portage Michigan-based company is expected to report a 8.2% increase in revenue to $5.406 billion from $5 billion a year ago, according to the mean estimate from 24 analysts, based on LSEG data.
S
Reuters - 2 buwan ang nakaraan

Some medical device makers rise, while others tip lower after J&J results

BUZZ-Some medical device makers rise, while others tip lower after J&J results ** Some medical device manufacturers rise after Johnson & Johnson's JNJ.N results, while others fall ** Zimmer Biomet ZBH.N rise 2.9% to $110.58, Medtronic MDT.N gain 2.45% to $80.01, Abbott ABT.N rise 2.10% to $104.90, Stryker SYK.N up 1.04% at $336.90 ** Shares of Intu
A
C
S
Z
Reuters - 2 buwan ang nakaraan

J&J beats Wall St estimates on strong drug sales ahead of Stelara competition

CORRECTED-UPDATE 3-J&J beats Wall St estimates on strong drug sales ahead of Stelara competition Corrects paragraph 4 as J&J CFO did not suggest pending Stelara insurance contracts would be 'favorable' By Patrick Wingrove and Bhanvi Satija July 17 (Reuters) - Johnson & Johnson JNJ.N beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara .
A
S
Reuters - 2 buwan ang nakaraan

Stryker Completes Acquisition Of Artelon

BRIEF-Stryker Completes Acquisition Of Artelon July 15 (Reuters) - Stryker Corp SYK.N : STRYKER COMPLETES ACQUISITION OF ARTELON, INC. Source text for Eikon: ID:nBw2Q55RHa Further company coverage: SYK.N
S
Reuters - 3 buwan ang nakaraan

Smith & Nephew faces long and painful activist fix

BREAKINGVIEWS-Smith & Nephew faces long and painful activist fix The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, July 4 (Reuters Breakingviews) - Smith & Nephew SN.L should prepare for a long and painful activist treatment. On Thursday, Swedish investor Cevian Capital announced it had taken a 5% stake in the $11 billion UK-listed maker of hip joints and wound care kit.
U
S
Reuters - 3 buwan ang nakaraan

Masimo COO Muhsin to resign if activist investor Politan takes control

UPDATE 2-Masimo COO Muhsin to resign if activist investor Politan takes control Adds background throughout July 1 (Reuters) - Masimo MASI.O Chief Operating Officer Bilal Muhsin has told the board he would resign if activist investor Politan Capital Management takes control of the company and CEO Joe Kiani is removed, according to a regulatory filing.
A
S

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.